Cellular plasticity confers migratory and invasive advantages to a population of glioblastoma-initiating cells that infiltrate peritumoral tissue

Stem Cells

Volumn 31, Issue 6, 2013, Pages 1075-1085

  Ruiz Ontañon, Patricia ^a   Orgaz, Jose L ^b   Aldaz, Beatriz ^c   Elosegui Artola, Alberto ^d   Martino, Juan ^a   Berciano, Maria T ^e   Montero, Juan A ^e   Grande, Lara ^a   Nogueira, Lorena ^a   Diaz Moralli, Santiago ^f   Esparís Ogando, Azucena ^g   Vazquez Barquero, Alfonso ^a   Lafarga, Miguel ^e   Pandiella, Atanasio ^g   Cascante, Marta ^f   Segura, Victor ^c   Martinez Climent, Jose A ^c   Sanz Moreno, Victoria ^b   Fernandez Luna, Jose L ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF NAVARRA   (Spain)

^d CEIT   (Spain)

^e UNIVERSITY OF CANTABRIA   (Spain)

^f UNIVERSITY OF BARCELONA   (Spain)

^g Centro de Investigacion del Cancer   (Spain)

Author keywords

Glioblastoma initiating cells; Integrin v 3; Invasion

Indexed keywords

BETA INTEGRIN; BETA3 INTEGRIN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; DIPEPTIDYL PEPTIDASE IV; DISRUPTED IN SCHIZOPHRENIA 1 PROTEIN; NESTIN; NEUREXIN; NEUROPILIN 1; PROTEIN P27; RAC PROTEIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SOX2; VITRONECTIN RECEPTOR;

ACTIN FILAMENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER INFILTRATION; CELL ADHESION; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL SHAPE; CELL SUBPOPULATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; COPY NUMBER VARIATION; DOWN REGULATION; GENE EXPRESSION; GLIOBLASTOMA; GLUCOSE INTAKE; IN VITRO STUDY; MECHANOTRANSDUCTION; MICROENVIRONMENT; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PLASTICITY; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT; UPREGULATION; XENOGRAFT; XENOTRANSPLANTATION;

ANIMALS; BRAIN NEOPLASMS; CELL LINE; CELL LINE, TUMOR; CELL MOVEMENT; CHICK EMBRYO; DOWN-REGULATION; FEMALE; GLIOBLASTOMA; HETEROGRAFTS; HUMANS; INTEGRIN ALPHAVBETA3; MICE; MICE, INBRED BALB C; NEOPLASM INVASIVENESS; NEOPLASTIC STEM CELLS; RAC GTP-BINDING PROTEINS; RHOA GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 84877937046     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.1349     Document Type: Article

References (63)

1. Giese A, Bjerkvig R, Berens ME et al. Cost of migration: Invasion of malignant gliomas and implications for treatment. J Clin Oncol 2003;21:1624-1636. (Pubitemid 46594118)
2. Kelly PJ, Daumas-Duport C, Kispert DB et al. Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms. J Neurosurg 1987;66:865-874. (Pubitemid 17085708)
3. Stevenson CB, Ehtesham M, McMillan KM et al. CXCR4 expression is elevated in glioblastoma multiforme and correlates with an increase in intensity and extent of peritumoral T2-weighted magnetic resonance imaging signal abnormalities. Neurosurgery 2008;63:560-569.
4. Martirosyan NL, Cavalcanti DD, Eschbacher JM et al. Use of in vivo near-infrared laser confocal endomicroscopy with indocyanine green to detect the boundary of infiltrative tumor. J Neurosurg 2011;115:1131-1138.
5. Nagashima G, Suzuki R, Hokaku H et al. Graphic analysis of microscopic tumor cell infiltration, proliferative potential, and vascular endothelial growth factor expression in an autopsy brain with glioblastoma. Surg Neurol 1999;51:292-299. (Pubitemid 29135915)
6. Eyler CE, Rich JN. Survival of the fittest: Cancer stem cells in therapeutic resistance and angiogenesis. J Clin Oncol 2008;26:2839-2845.
7. Glas M, Rath BH, Simon M et al. Residual tumor cells are unique cellular targets in glioblastoma. Ann Neurol 2010;68:264-269.
8. Raftopoulou M, Hall A. Cell migration: Rho GTPases lead the way. Dev Biol 2004;265:23-32. (Pubitemid 38018819)
9. Hirata E, Yukinaga H, Kamioka Y et al. In vivo fluorescence resonance energy transfer imaging reveals differential activation of Rho-family GTPases in glioblastoma cell invasion. J Cell Sci 2012;125:858-868.
10. Panopoulos A, Howell M, Fotedar R et al. Glioblastoma motility occurs in the absence of actin polymer. Mol Biol Cell 2011;22:2212-2220.
11. Kim HD, Guo TW, Wu AP et al. Epidermal growth factor-induced enhancement of glioblastoma cell migration in 3D arises from an intrinsic increase in speed but an extrinsic matrix- and proteolysis-dependent increase in persistence. Mol Biol Cell 2008;19:4249-4259.
12. Ulrich TA, de Juan Pardo EM, Kumar S. The mechanical rigidity of the extracellular matrix regulates the structure, motility, and proliferation of glioma cells. Cancer Res 2009;69:4167-4174.
13. DeMali KA, Wennerberg K, Burridge K. Integrin signaling to the actin cytoskeleton. Curr Opin Cell Biol 2003;15:572-582. (Pubitemid 37176966)
14. Dey N, Crosswell HE, De P et al. The protein phosphatase activity of PTEN regulates SRC family kinases and controls glioma migration. Cancer Res 2008;68:1862-1871. (Pubitemid 351416572)
15. Jiang G, Huang AH, Cai Y et al. Rigidity sensing at the leading edge through alphavbeta3 integrins and RPTPalpha. Biophys J 2006;90:1804-1809.
16. Besson A, Gurian-West M, Schmidt A et al. p27Kip1 modulates cell migration through the regulation of RhoA activation. Genes Dev 2004;18:862-876. (Pubitemid 38529656)
17. Nogueira L, Ruiz-Ontanon P, Vazquez-Barquero A et al. Blockade of the NFkappaB pathway drives differentiating glioblastoma-initiating cells into senescence both in vitro and in vivo. Oncogene 2011;30:3537-3548.
18. McCord AM, Jamal M, Shankavaram UT et al. Physiologic oxygen concentration enhances the stem-like properties of CD133+ human glioblastoma cells in vitro. Mol Cancer Res 2009;7:489-497.
19. Trinidad EM, Ballesteros M, Zuloaga J et al. An impaired transendothelial migration potential of chronic lymphocytic leukemia (CLL) cells can be linked to ephrin-A4 expression. Blood 2009;114:5081-5090.
20. Gutierrez O, Pipaon C, Inohara N et al. Induction of Nod2 in myelomonocytic and intestinal epithelial cells via nuclear factor-kappa B activation. J Biol Chem 2002;277:41701-41705. (Pubitemid 35257477)
21. Sanz-Moreno V, Gadea G, Ahn J et al. Rac activation and inactivation control plasticity of tumor cell movement. Cell 2008;135:510-523.
22. Nielaender I, Martin-Subero JI, Wagner F et al. Partial uniparental disomy: A recurrent genetic mechanism alternative to chromosomal deletion in malignant lymphoma. Leukemia 2006;20:904-905.
23. Roy S, Singh RP, Agarwal C et al. Downregulation of both p21/Cip1 and p27/Kip1 produces a more aggressive prostate cancer phenotype. Cell Cycle 2008;7:1828-1835. (Pubitemid 351988749)
24. Coso OA, Chiariello M, Yu JC et al. The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway. Cell 1995;81:1137-1146.
25. Ponomarev V, Doubrovin M, Serganova I et al. A novel triple-modality reporter gene for whole-body fluorescent, bioluminescent, and nuclear noninvasive imaging. Eur J Nucl Med Mol Imaging 2004;31:740-751. (Pubitemid 38647915)
26. Laks DR, Masterman-Smith M, Visnyei K et al. Neurosphere formation is an independent predictor of clinical outcome in malignant glioma. Stem Cells 2009;27:980-987.
27. Singec I, Knoth R, Meyer RP et al. Defining the actual sensitivity and specificity of the neurosphere assay in stem cell biology. Nat Methods 2006;3:801-806. (Pubitemid 44445827)
28. Sakariassen PO, Prestegarden L, Wang J et al. Angiogenesis-independent tumor growth mediated by stem-like cancer cells. Proc Natl Acad Sci USA 2006;103:16466-16471. (Pubitemid 44715219)
29. Ishizawa K, Rasheed ZA, Karisch R et al. Tumor-initiating cells are rare in many human tumors. Cell Stem Cell 2010;7:279-282.
30. Chen R, Nishimura MC, Bumbaca SM et al. A hierarchy of self-renewing tumor-initiating cell types in glioblastoma. Cancer Cell 2010;17:362-375.
31. Evdokimova V, Tognon C, Ng T et al. Reduced proliferation and enhanced migration: Two sides of the same coin? Molecular mechanisms of metastatic progression by YB-1. Cell Cycle 2009;8:2901-2906.
32. Hoek KS, Eichhoff OM, Schlegel NC et al. In vivo switching of human melanoma cells between proliferative and invasive states. Cancer Res 2008;68:650-656. (Pubitemid 351206739)
33. Unsgaard G, Rygh OM, Selbekk T et al. Intra-operative 3D ultrasound in neurosurgery. Acta Neurochir 2006;148:235-253. (Pubitemid 43341021)
34. Engler AJ, Sen S, Sweeney HL et al. Matrix elasticity directs stem cell lineage specification. Cell 2006;126:677-689. (Pubitemid 44233625)
35. Lakshmi MS, Sherbet GV. Measurement of DNA content and nuclear pleomorphism in metastatic variants of the B16 murine melanoma and hamster lymphoma and its liver metastasis using image analysis techniques. Clin Exp Metastasis 1990;8:553-566. (Pubitemid 20355469)
36. Nakashima Y, Yao T, Hirahashi M et al. Nuclear atypia grading score is a useful prognostic factor in papillary gastric adenocarcinoma. Histopathology 2011;59:841-849.
37. Sahai E, Marshall CJ. Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis. Nat Cell Biol 2003;5:711-719. (Pubitemid 36986778)
38. Chan AY, Coniglio SJ, Chuang YY et al. Roles of the Rac1 and Rac3 GTPases in human tumor cell invasion. Oncogene 2005;24:7821-7829. (Pubitemid 41715188)
39. Yamazaki D, Kurisu S, Takenawa T. Involvement of Rac and Rho signaling in cancer cell motility in 3D substrates. Oncogene 2009;28:1570-1583.
40. Roca-Cusachs P, Gauthier NC, Del Rio A et al. Clustering of alpha(5)beta(1) integrins determines adhesion strength whereas alpha(v)beta(3) and talin enable mechanotransduction. Proc Natl Acad Sci USA 2009;106:16245-16250.
41. Davis GE. Affinity of integrins for damaged extracellular matrix: Alpha v beta 3 binds to denatured collagen type I through RGD sites. Biochem Biophys Res Commun 1992;182:1025-1031.
42. Sato H, Takino T. Coordinate action of membrane-type matrix metalloproteinase-1 (MT1-MMP) and MMP-2 enhances pericellular proteolysis and invasion. Cancer Sci 2010;101:843-847.
43. Sipes NS, Feng Y, Guo F et al. Cdc42 regulates extracellular matrix remodeling in three dimensions. J Biol Chem 2011;286:36469-36477.
44. Belletti B, Pellizzari I, Berton S et al. p27kip1 controls cell morphology and motility by regulating microtubule-dependent lipid raft recycling. Mol Cell Biol 2010;30:2229-2240.
45. Kranenburg O, Poland M, Gebbink M et al. Dissociation of LPA-induced cytoskeletal contraction from stress fiber formation by differential localization of RhoA. J Cell Sci 1997;110:2417-2427. (Pubitemid 127699156)
46. Woo S, Gomez TM. Rac1 and RhoA promote neurite outgrowth through formation and stabilization of growth cone point contacts. J Neurosci 2006;26:1418-1428. (Pubitemid 43237012)
47. Elkin BS, Azeloglu EU, Costa KD et al. Mechanical heterogeneity of the rat hippocampus measured by atomic force microscope indentation. J Neurotrauma 2007;24:812-822. (Pubitemid 46799273)
48. Giese A, Laube B, Zapf S et al. Glioma cell adhesion and migration on human brain sections. Anticancer Res 1998;18:2435-2447. (Pubitemid 28386531)
49. Carbonell WS, Ansorge O, Sibson N et al. The vascular basement membrane as "soil" in brain metastasis. PLoS One 2009;4:e5857.
50. Ridley AJ, Schwartz MA, Burridge K et al. Cell migration: Integrating signals from front to back. Science 2003;302:1704-1709. (Pubitemid 37505725)
51. Bourdoulous S, Orend G, MacKenna DA et al. Fibronectin matrix regulates activation of RHO and CDC42 GTPases and cell cycle progression. J Cell Biol 1998;143:267-276. (Pubitemid 28480534)
52. Ahn J, Sanz-Moreno V, Marshall CJ. The metastasis gene NEDD9 product acts through integrin beta3 and Src to promote mesenchymal motility and inhibit amoeboid motility. J Cell Sci 2012;125:1814-1826.
53. Tabatabai G, Tonn JC, Stupp R et al. The role of integrins in glioma biology and anti-glioma therapies. Curr Pharm Des 2011;17:2402-2410.
54. Nguyen L, Besson A, Heng JI et al. p27kip1 independently promotes neuronal differentiation and migration in the cerebral cortex. Genes Dev 2006;20:1511-1524. (Pubitemid 43830657)
55. Wu FY, Wang SE, Sanders ME et al. Reduction of cytosolic p27(Kip1) inhibits cancer cell motility, survival, and tumorigenicity. Cancer Res 2006;66:2162-2172.
56. Schiappacassi M, Lovat F, Canzonieri V et al. p27Kip1 expression inhibits glioblastoma growth, invasion, and tumor-induced neoangiogenesis. Mol Cancer Ther 2008;7:1164-1175.
57. Ho B, Olson G, Figel S et al. Nanog increases focal adhesion kinase (FAK) promoter activity and expression and directly binds to FAK protein to be phosphorylated. J Biol Chem 2012;287:18656-18673.
58. Yang HW, Menon LG, Black PM et al. SNAI2/Slug promotes growth and invasion in human gliomas. BMC Cancer 2010;10:301.
59. Singh KK, De Rienzo G, Drane L et al. Common DISC1 polymorphisms disrupt Wnt/GSK3beta signaling and brain development. Neuron 2011;72:545-558.
60. Rueckert C, Haucke V. The oncogenic TBC domain protein USP6/TRE17 regulates cell migration and cytokinesis. Biol Cell 2012;104:22-33.
61. Chicoine MR, Zahner M, Won EK et al. The in vivo antitumoral effects of lipopolysaccharide against glioblastoma multiforme are mediated in part by Toll-like receptor 4. Neurosurgery 2007;60:372-380.
62. Kleaveland B, Zheng X, Liu JJ et al. Regulation of cardiovascular development and integrity by the heart of glass-cerebral cavernous malformation protein pathway. Nat Med 2009;15:169-176.
63. Soda Y, Marumoto T, Friedmann-Morvinski D et al. Transdifferentiation of glioblastoma cells into vascular endothelial cells. Proc Natl Acad Sci USA 2011;108:4274-4280.